William K. Heiden - Mar 31, 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact
Stock symbol
ATRA
Transactions as of
Mar 31, 2024
Transactions value $
$0
Form type
4
Date filed
4/2/2024, 06:12 PM
Previous filing
Nov 14, 2023
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Award $0 +150K +71.77% $0.00 359K Mar 31, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units shall vest on the date of the Issuer's annual meeting of stockholders for the calendar year 2025, subject to the Reporting Person's continuous service.